Syros pharmaceuticals merger
WebApr 15, 2024 · Syros Pharmaceuticals has a 1-year low of $2.42 and a 1-year high of $12.93. Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) last released its quarterly earnings … WebSep 16, 2024 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of …
Syros pharmaceuticals merger
Did you know?
WebJul 5, 2024 · In the merger, Syros expects to issue approximately 74.3 million shares of its common stock to TYME stockholders to acquire TYME's expected net cash at closing and … WebAt Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing …
WebTyme Technologies, Inc., a biotechnology company developing cancer metabolism-based therapies, completed its acquisition by merger with Syros Pharmaceuticals, Inc., a leader … WebApr 7, 2024 · Syros Pharmaceuticals is part of the Pharmaceuticals industry, and located in Massachusetts, United States. Syros Pharmaceuticals Location 35 Cambridge Park Dr, Cambridge, Massachusetts, 02140, United States Description Read More Industry Pharmaceuticals Healthcare Discover more about Syros Pharmaceuticals Beth Ann Work …
WebSyros Pharmaceuticals, Inc., a Delaware corporation, or Syros, and Tyme Technologies, Inc., a Delaware corporation, or Tyme, entered into an Agreement and Plan of Merger, or the … WebJul 5, 2024 · Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement News Download as PDF July 05, 2024 Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance …
WebSep 16, 2024 · CAMBRIDGE, Mass., September 16, 2024 -- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that …
WebExhibit 4.2 . SYROS PHARMACEUTICALS, INC. and . Trustee . INDENTURE . Dated as of SENIOR DEBT SECURITIES lake county fl waste scheduleWebJul 5, 2024 · Syros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME ), including its pipeline assets and net cash, after … lake county fl waterfront homes for saleWebNov 22, 2024 · Syros and Tyme Technologies Announce Stockholder Approval of Merger Sep 13, 2024 Syros Receives FDA Orphan Drug Designation for SY-5609 for the Treatment … lake county fl water authorityWebApr 15, 2024 · Syros Pharmaceuticals, Inc engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by... lake county fl voting locationsWebSep 20, 2024 · Syros Pharmaceuticals has recently acquired its peer Tyme Technologies. The sole purpose of the merger was to acquire TYME's cash balance. Concurrently with … lake county fl water departmentWebKEY WINS: Steered the strategic and operational integration of Tyme Inc. into Syros Pharmaceuticals following an acquisition. Now driving business for an artificial intelligence-powered... lake county fl water and sewerWebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … lake county fl weather alerts